Eli Lilly Is Diving Deeper Into AI Drug Discovery With Expanded Insilico Partnership

Fed Officials Warn on Inflation, Job Market Outlook The Iran War Has Shaken Up Asset Prices The War Is Crushing Consumer Sentiment Eli Lilly Is Diving Deeper Into AI Drug Discovery With Expanded Insilico Partnership Stocks Plunge, Oil Surges Top Stories Eli Lilly shares are down nearly 20% since the start of the year. Mark Felix / Bloomberg / Getty Images Close Key Takeaways Eli Lilly is doubling down on AI drug development with its latest deal. Eli Lilly (LLY) is expanding its partnership with Ins ...